South China Morning Post · General

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

· By Julie Zhang
Story summary

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.